课题基金 / 基金详情

Elucidation of role of beta ig-3 derived from osteoclasts in bone resorption and formation

Elucidation of role of beta ig-3 derived from osteoclasts in bone resorption and formation
阐明破骨细胞衍生的 β ig-3 在骨吸收和形成中的作用
批准号:
15591946
负责人:
HAKEDA Yoshiyuki
金额:
$2.24万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004

项目摘要

项目成果

HAKEDA Yoshiyuki的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Background : Osteoclastogenesis is promoted by a trigger molecule, receptor activator of NF-κB(RANKL). However, the molecular mechanism for RANKL-induced osteoclast formation and how the osteoclast progenitors are committed to differentiate into osteoclasts have remained to be investigated. Through our project to seek for master genes for osteoclast generation dependent of RANKL-signals, we identified beta ig-h3, which is induced to be expressed in osteoclast progenitors in response to RANKL. In this study, we attempted to elucidate the role of osteoclast progenitor-derived beta ig-h3 in bone resorption by osteoclasts and bone formation by osteoblasts.Methods : We employed in vitro culture system of M-CSF dependent bone marrow cells-derived osteoclast progenitors for osteoclast formation. We searched for genes expressed in osteoclast progenitors that are dependent on RANKL-stimuli by fluorescent differential display.Results and Discussion : In osteoclast progenitors, gene expression of … More beta ig-h3 was induced within early times after exposure to RANKL. The gene expression was also induced by TGF-β and further amplified by the simultaneous addition of RANKL and TGF-β. The induction occurred earlier than the expressions of osteoclast differentiation-related molecules such as tartrate-resistant acid phosphatase (TRAP), cathepsin K, and calcitonin receptors. Since other bone cells such as osteoblasts did not express beta ig-h3, the expression is likely to be specific for osteoclast lineage. Beta ig-h3 contains RGD sequence, and is considered to be an adherent protein that associates with some integrins. Among such adherent proteins, osteopontin is also well known to be expressed in osteoclasts. However, the osteopontin is also expressed in osteoblasts, and is not specific for osteoclasts. In addition, the osteopontin expression did not depended on RANKL. We cloned full-length gene of beta ig-h3, and confirmed from compelling expression in HEK293 cells that the adherent molecule was a secretion protein. Since beta ig-h3 interacts with some integrins, we examined the expression of integrins in osteoclast progenitors. Among these integrins, expression of a V and β3 integrins was linked to osteoclast formation as well as beta ig-h3. Neutralizing antibody against β3 blocked the osteoclast generation in a culture of osteoclast progenitors with M-CSF, TGF-β, and RANKL. Since the culture of osteoclast progenitors does not contain other cells, the molecule associated with β3 integrin is the progenitor-derived one. Taken together, beta ig-h3 would play a possible role in Osteoclastogenesis as a positive regulator. Less
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
Dexamethasone enhances osteoclast formation synergistically with transforming growth factor-b by stimulating the priming of osteoclast progenitors for differentiation into osteoclasts
地塞米松通过刺激破骨细胞祖细胞分化为破骨细胞,与转化生长因子-b 协同增强破骨细胞形成
DOI: --
发表时间: 2003
期刊: J. Biol. Chem. 278
影响因子: --
作者: [Takuma A, Kaneda T, Sato T, Ninomiya S, Kumegawa M, Hakeda Y]
通讯作者: Hakeda Y
Dexamethasone enhances osteoclast formation synergistically with transforming growth factor-b by stimulating the priming of osteolast progenitors for differentiation into osteoclasts.
地塞米松通过刺激破骨细胞祖细胞分化为破骨细胞,与转化生长因子-b 协同增强破骨细胞形成。
DOI: --
发表时间: 2003
期刊: J.Biol.Chem. 278
影响因子: --
作者: [Takuma, A., Kaneda, T., Sato, T., Ninomiya, S., Kumegawa, M., Hakeda, Y.]
通讯作者: Y.
The active metabolite of lefluonomide, A771726,inhibits both the generation of and the bone-resorbing activity of osteoclasts by acting directly on cells of the osteoclast lineage.
来氟诺米特的活性代谢物 A771726 通过直接作用于破骨细胞谱系的细胞来抑制破骨细胞的生成和骨吸收活性。
DOI: --
发表时间: 2004
期刊: J.Bone Miner.Metab. 22
影响因子: --
作者: [Kobayashi, Y., Ueyama, S., Arai, Y., Yoshida, Y., Kaneda, T., Sato, T., Shin, K., Kumegawa, M., Hakeda, Y.]
通讯作者: Y.
Takuma, A., Kaneda, T., Sato, T., Ninomiya, S., Kumegawa, M., Hakeda Y.: "Dexamethasone enhances osteoclast formation synergistically with transforming growth factor-β by stimulating the priming of osteoclast progenitors for differentiation into osteoclas
Takuma, A.、Kaneda, T.、Sato, T.、Ninomiya, S.、Kumekawa, M.、Hakeda Y.:“地塞米松通过刺激破骨细胞祖细胞的分化,与转化生长因子-β 协同增强破骨细胞的形成进入破骨细胞
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Elucidation of Involvement of LOX-1 in inflammatory bone destruction and the molecular mechanism for the LOX-1 actions, and an approach to develop the new drug for bone diseases.
  • 批准号:
    16H05505
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $11.07万
  • 财政年份:
    2016
  • 负责人:
    HAKEDA Yoshiyuki
  • 依托单位:
Trial study for the establishment of the new therapeutical method for periodontal disease that targets oxidation LDL receptor LOX-1.
  • 批准号:
    26670895
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
  • 资助金额:
    $2.33万
  • 财政年份:
    2014
  • 负责人:
    HAKEDA Yoshiyuki
  • 依托单位:
The elucidation of the role of lipid in bone resorption of inflammatory bone diseases; in particular, the exploration of the role of LOX-1 as an oxidized LDL receptor
  • 批准号:
    25293376
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $11.32万
  • 财政年份:
    2013
  • 负责人:
    HAKEDA Yoshiyuki
  • 依托单位:
DEPENDENCY OF OSTEOCLAST DIFFERENTIATION ON EXOGENOUS CHOLESTEROL AND ROLE OF CAVEOLIN-1 IN OSTEOCLASTOGENESIS
  • 批准号:
    21592341
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.91万
  • 财政年份:
    2009
  • 负责人:
    HAKEDA Yoshiyuki
  • 依托单位: